Background: The [
Introduction
There is a well-recognized need for a safe and simple method of assessing fat digestion, especially in children with cystic fibrosis (CF) (Amarri and Weaver, 1995) . CF is the most common cause of exocrine pancreatic insufficiency in children. The mixed triacylglycerol (MTG) 13 C-breath test is a non-invasive measure of intraluminal fat digestion (Ghoos et al., 1981; Vantrappen et al., 1989) . 13 C-breath tests are particularly attractive for use in children because they are non-invasive, and pose no radiation hazard. The 13 C-MTG breath test has been used to assess the need for pancreatic enzyme replacement therapy (PERT) in children with CF and to assess the ideal dose (Amarri et al., 1997; de Boeck et al., 1998) , but it has not been widely adopted because it lacks specificity.
MTG is a synthetic triacylglycerol (1,3 distearyl 2-[1- 13 C]octanoyl-glycerol). Pancreatic lipases preferentially hydrolyse triacylglycerol at the sn-1 and -3 positions, releasing 13 C-labelled octanoate and monoacylglycerol, which are rapidly absorbed independently of bile salts, and oxidized in the liver with the generation of 13 CO 2 . Quantitation of tracer recovery requires knowledge of carbon dioxide production rate (VCO 2 ) because labelled CO 2 originating from oxidation of the tracer is diluted by endogenously produced CO 2 from metabolism. A resting value based on basal metabolic rate (BMR) is often assumed (Swart et al., 1997; van Dijk-van Aalst et al., 2001) , but even if resting VCO 2 is measured (Kalivianakis et al., 1997; Amarri et al., 1998) , this may not be appropriate unless subjects remain seated and fast for the duration of the test. If subjects are not at rest and not in the post-absorptive state, for example, after an overnight fast, when all food from the last meal has been absorbed from the small intestine, use of resting VCO 2 will underestimate the true CO 2 production rate resulting in an underestimation of the quantity of tracer recovered. We have previously shown that negligible amounts of 13 C are excreted in stool following ingestion of [ The hypothesis tested in this study is that the poor specificity of the [ 13 C]MTG breath test is owing, in part, to lack of knowledge of the true CO 2 production rate during the test. The aims of the study were to use calibrated heart rate monitors to estimate non-resting VCO 2 during the [ 13 C]MTG breath test in healthy adults, healthy children and children with CF, to determine the reference range of 13 C excretion in healthy subjects, and to determine the physical activity level (PAL) during the test so that cumulative percent dose recovered (cPDR) in children with CF can be corrected for non-resting VCO 2 without the need for individual heart rate calibration. 
Materials and methods

C]MTG breath test
Subjects were asked to avoid foods that are naturally enriched with 13 C in the days preceding the test (Schoeller et al., 1980; Morrison et al., 2000) . After an overnight fast, six children with CF,10 healthy control children and eight healthy adults ingested 10 mg kg À1 body weight [ 13 C]MTG (Cambridge Isotopes Laboratory Inc., Andover, MA, USA) baked in a biscuit composed of 90 g rolled oats, 40 g butter and 40 g honey (weighed to within 1 g). The honey and butter were melted over a bain-marie. The tracer (weighed to 0.001 g) was stirred into the melted ingredients until dissolved and distributed evenly. The oats were added and the mixture and stirred thoroughly until all the liquid was absorbed. The mixture was spread over the bottom of an aluminium foil-lined tray (160 mm 2 , surface area 0.0256 m 2 or 170 mm diameter, surface area 0.0227 m 2 ), and baked at 1301C for 15 min in a fan-assisted oven. The bowls, spoons, baking tray and foil were weighed before and after use, so that the tracer weight could be corrected for losses during preparation of the test meal (Slater et al., 2002b) . The nutritional composition of the test meal was calculated from food composition tables (Holland et al., 1991) . This recipe provides 3.13 MJ and is sufficient for two 75 kg adults or 3-4 children, depending on their age and size. Subjects were given a portion equivalent to 17-20% of their daily energy requirements (Department of Health, 1991) together with a drink of unsweetened orange juice or water, as they preferred. In vitro experiments had confirmed that the tracer was homogeneously distributed through the biscuit and there was no loss during preparation (Slater, 2004) . Children with CF did not take their PERT with the test meal. A light lunch, composed of foods with low 13 C natural abundance (Morrison et al., 2000) was taken 4 h after the test meal. Children with CF took their usual dose of PERT with this meal.
Heart rate monitors (Polar Vantage NV, Polar Electro Oy, Kempele, Finland) were worn throughout the test. Alveolar breath was sampled by exhalation into an Exetainer breathsampling vial (Labco, High Wycombe, UK) through a straw until condensation appeared on the inside wall of the vial (Slater et al., 2004) . The cap was replaced immediately. Breath samples were collected at baseline and every 20 min for 6 h. Resting VCO 2 was measured 3 h after the test meal using a ventilated hood indirect calorimeter (GEM, Nutren Technologies, Manchester, UK). Body weight was measured (to 0.1 kg) using Seca scales (model 707, Seca Ltd, Birmingham, UK). Height was measured (to within 1 mm) using a Holtain stadiometer (Holtain, Crymych, Dyfed, UK). Body mass index (kg m
À2
) was calculated in adults. In children, body mass index was expressed as standard deviation scores relative to the UK 1990 reference data (Cole et al., 1995) using software from the Child Growth Foundation (London, UK).
Eight healthy control children and one child with CF performed the test in the familiar surroundings of their own homes. Two healthy controls and five children with CF performed the test at the day care ward at the Royal Hospital for Sick Children, Glasgow. Resting metabolic rate was measured and the heart rate calibration procedure described below was performed within 1 week of the breath test in children, who performed the test at home. Breath sample collection was supervised by the same researcher in all tests to avoid systematic differences in sample collection.
Calibration of heart rate monitors At the end of the test or within 1 week, heart rate was calibrated against VCO 2 in all subjects (adults, healthy children and children with CF) by making simultaneous measurements with the subject lying on a bed, sitting, standing and during a continuous series of increasing workloads on a bicycle ergometer (Slater et al., 2006) . Data (averaged over 1-min periods) were downloaded from the heart rate monitor and the indirect calorimeter to a personal computer (PC) and read into a proprietary spreadsheet (Microsoft Excel 97 SR2). Resting data collected earlier in the day were also included. Time data were matched to give simultaneous readings of both heart rate and VCO 2 . Heart rate was smoothed by averaging data two points forward of any particular time point. Smoothing heart rate in this way gives a more accurate estimate of resting VCO 2 (Slater et al., 2006) . VCO 2 (mmol min À1 m
) was plotted against heart rate with heart rate the independent variable plotted on the x axis and VCO 2 the dependent variable plotted on the y axis. A sigmoid function was fitted to the data using the 'Solver' function of Microsoft Excel (Walsh and Diamond, 1995) . Solver used non-linear regression to determine, by iteration, the value of the constants that gave the line of best fit through the data (Motulsky and Ransnas, 1987) .
Determination of percentage dose recovered in breath CO 2 Breath 13 CO 2 abundance was measured by continuous-flow isotope ratio mass spectrometry as previously described (Prosser et al., 1991; Slater et al., 2004) . The system comprised a 20-20 isotope ratio mass spectrometer (IRMS) interfaced to an automated breath carbon analyser (Hydra, PDZ Europa, Crewe, UK). Measurements were made against a reference gas traceable to international standards (Coplen, 1996) . Variability in the amount of CO 2 in the breath-sampling vial can be tolerated as the measured isotope ratio does not vary with sample size over the expected concentration range. This phenomenon is known as linearity. The IRMS used in this study is linear over the range from 0.5 to 7% CO 2 in air (Slater, 2004) . The amount of CO 2 in exhaled breath is usually between 2 and 5%. Data from vials containing less than 0.5% CO 2 were rejected.
Enrichment was calculated by subtracting the abundance of the baseline sample (p.p.m. 13 C) from that of the postdose sample (Schoenheimer and Rittenberg, 1939; Slater et al., 2001 IDECG, 1990) . 3. A constant resting value of VCO 2 measured using a ventilated hood indirect calorimeter. 4. Continuously measured non-resting VCO 2 estimated from heart rate using the parameters from the sigmoid function fitted to each individual's calibration data. When VCO 2 was estimated from heart rate, a different value was used to calculate PDR in each breath sample. The VCO 2 value was the mean within 710 min of the time of the breath sample.
Cumulative excretion of 13 C in breath CO 2 (cPDR) was calculated using the trapezoidal rule.
Physical activity during the [ 13 C]MTG breath test
PAL during the [ 13 C]MTG breath test was taken as cPDR calculated using VCO 2 estimated from heart rate divided by cPDR calculated using measured resting VCO 2 (Method 4 above divided by Method 3). This is mathematically equivalent to non-resting VCO 2 divided by resting VCO 2 , which equates to total energy expenditure (TEE)/resting energy expenditure.
Statistics
Differences between groups were assessed using a MannWhitney U-test at the 95% confidence level using standard statistical software (Minitab for Windows, Release 11.2).
Determining the cutoff of the [
C]MTG breath test
The appropriate cutoff for the test using each value of VCO 2 as described above was determined using two graph-receiver operator characteristics (TG-ROC; Greiner et al., 1995) at the 95% accuracy level, using a freely available Excel spreadsheet template downloaded from http://city.vetmed.fu-berlin. de/~mgreiner/TG-ROC/tgroc.htm. The spreadsheet contains a test for normality. TG-ROC is a plot of the test sensitivity (Se) and specificity (Sp) against the threshold (cutoff) value assuming the latter to be an independent variable. A cutoff (d 0 ) that realises equal test parameters (Se ¼ Sp ¼ y 0 , thetazero) can be obtained as the intersection point of the two graphs at the chosen level of accuracy (95 or 90%). As the value for y 0 (theta-zero) is below the chosen accuracy level, two cutoff values are selected that represent the bounds of an intermediate range that can be considered as the equivocal range for the clinical interpretation of test results (Greiner et al., 1995) . The proportion of the measurement range that gives unambiguous test results is the valid range proportion (VRP). VRP and y 0 (theta-zero) can be used to compare tests, as they do not depend upon the selection of a single cutoff point. The ideal test has both equal to unity and an intermediate range of zero.
The positive and negative predictive values for each MTG test were calculated (Bland, 1995) using a prevalence of pancreatic insufficiency in the study population of 0.21 (five out of 24 subjects, who had CF and had been prescribed PERT). These were compared with the values obtained by Vantrappen et al. (1989) in their validation study of the MTG test in adult patients with pancreatic disease.
Ethical considerations
The study was carried out in accordance with the principles outlined in the Declaration of Helsinki. The work described here posed no risk to the subjects taking part in the study.
Non-resting VCO 2 improves MTG breath test C Slater et al Subjects were free to drop out of the study at any time. Children with CF were recruited from those attending the Royal Hospital for Sick Children, Yorkhill, Glasgow, but were free of pulmonary infection at the time of the test. Ethical approval was obtained from the Yorkhill Research Ethics Committee for the study involving children and from the University of Glasgow Ethics Committee for Non Clinical Research Involving Human Subjects for the study involving adults. The purpose of the study was carefully explained and written informed consent was obtained from all adult subjects taking part in the study. In the case of children, their written informed consent and also that of their parents was obtained.
Results
The characteristics of the subjects studied are shown in Table 1 . There was no significant difference in age, height or weight between healthy control children and children with CF, but the median body mass index standard deviation score was significantly lower in children with CF (P ¼ 0.04). One child with CF was not pancreatic insufficient as assessed using the MTG breath test. This child had not been prescribed PERT.
The heart rate monitors and calibration procedure were well tolerated by all subjects including children with CF, who were free from pulmonary infection at the time of the test. Children with CF preferred the breath test to alternative non-invasive tests of exocrine pancreatic function such as 3-day faecal fat estimations. There was no problem in sampling breath by blowing through a straw in children with CF. Figure 1 and Table 2 show the cPDR in 6 h following a test meal containing [
13 C]MTG. The median (range) PAL in adults, who remained seated as much as possible during the test, was 1.3 (1.0-1.6). The PAL was 1.7 (1.0-2.2) in children who performed the test at home and 1.3 (1.2-1.5) in children who came to the hospital, where there was less choice of activity to occupy them between breath-sampling times. Table 3 shows data from individual children with CF. One patient was taking high-dose PERT. This patient had lowest recovery of 13 C in breath CO 2 , confirming that the patient with poorest pancreatic function had the lowest recovery of 13 C in breath, and the patient who was not taking PERT had the highest.
There was no significant difference in cPDR between healthy adults and healthy children when PDR was calculated using VCO 2 predicted using the Schofield equations, using resting VCO 2 measured by indirect calorimetry and non-resting VCO 2 predicted from heart rate. Therefore, data from all healthy subjects, plus the child with CF, who was not taking PERT were combined to determine the reference range (mean72 s.d.) in pancreatic-sufficient subjects Use of a variable value of nonresting CO 2 production rate (VCO 2 ) estimated using individually calibrated heart rate monitors (ICHRM, }~) improved the specificity of the test compared to using resting VCO 2 , whether predicted from body surface area (J K) (Shreeve et al., 1970) or BMR (n m) (Schofield, 1985) , or measured using a ventilated hood indirect calorimeter (& '). Also shown is the median (x), with range, cPDR from pancreatic-insufficient children with CF calculated using measured resting VCO 2 with a constant PAL of 1.3 (n ¼ 44, this study plus data from Amarri et al., 1997). ------Cutoff value of 25.9 determined by TG-ROC (n ¼ 69, 24 subjects from this study plus 45 additional children with CF). ¼ 19) . The reference range of cPDR in 6 h following ingestion of [ 13 C]MTG was 24-58% when VCO 2 was estimated continuously from heart rate. Figure 2 shows the TG-ROC analysis of the cPDR in 6 h, calculated using nonresting VCO 2 estimated from heart rate. The cutoff point is the threshold value where the sensitivity is equal to the specificity. The cutoff point was determined using nonparametric statistics, as data from pancreatic-insufficient subjects were not normally distributed. The cutoff point was 25%, with sensitivity and specificity equal to 0.99. There was no intermediate range and therefore the VRP was 1.0. The positive and negative predictive values were 0.99. For comparison, the reference range calculated using a constant value of VCO 2 of 5 mmol min À1 m À2 (Shreeve et al., 1970) was 18-43% and that using a constant value of measured resting VCO 2 was 17-40%. In both cases, the cutoff point was 20% with sensitivity and specificity ¼ 0.83, giving an equivocal range of 17-20% using predicted resting VCO 2 and 18-20% using measured resting VCO 2 . The VRP was 0.92 using predicted resting VCO 2 and 0.95 using measured resting VCO 2 . The positive predictive value (PPV) was 0.67 and the negative predictive value was 0.94. Use of individually calibrated heart rate monitors to estimate VCO 2 during the [ 13 C]MTG test improved the PPV of the test from 0.67 using resting VCO 2 to 0.99 using nonresting VCO 2 estimated from heart rate.
Non-resting
VCO 2 improves MTG breath test C Slater et al (n
Discussion
In 13 C-breath tests, an increase in VCO 2 will result in dilution of labelled CO 2 from the tracer by unlabelled CO 2 leading to low 13 C enrichment in breath CO 2 . VCO 2 is Physical activity level (PAL) ¼ cPDR calculated using non-resting VCO 2 estimated from heart rate (HR) divided by cPDR calculated using measured resting VCO 2 . Pancreatic sufficient (PS) children include eight healthy controls who performed the test in the familiar surroundings of their own homes plus two controls and one child with cystic fibrosis who came to the hospital. Four of the five children with cystic fibrosis, who were pancreatic insufficient (PI), performed the test at the day care ward at the Royal Hospital for Sick Children, Glasgow. The remaining PI child with cystic fibrosis performed the test at home. 
Sensitivity Specificity
Specificity
Figure 2 TG-ROC analysis to determine the cutoff point in the [ 13 C]MTG breath test. Sensitivity and specificity are shown as a function of the threshold value of cumulative PDR (cPDR) in 6 h, calculated using non-resting CO 2 production rate. The cutoff is the point where sensitivity is equal to specificity. In this example, sensitivity and specificity equal 0.99 and the cutoff is 25.4%.
Non-resting VCO 2 improves MTG breath test C Slater et al usually expressed relative to body surface area to take into account differences with body size. Total CO 2 production includes resting VCO 2 plus post-prandial or diet-induced thermogenesis (DIT) plus CO 2 produced during physical activity. There may also be an increase above BMR owing to infection or inflammation in some subjects. DIT accounts for approximately 10% TEE over a 24-h period. DIT was measured in the adults taking part in this study. VCO 2 in the post-prandial period (2 h after the test meal) was 1.16 times resting VCO 2 (Slater, 2004) . Subjects taking part in 13 C-breath tests are instructed to sit quietly in a chair to minimise the increase in VCO 2 caused by physical activity. In addition, children with CF may have elevated resting VCO 2 compared to healthy children (Amarri et al., 1998) . Heart rate monitors were used in preference to motion sensors (Schulz et al., 1989; Montgomery et al., 2004) because motion sensors do not take account of increases in metabolic rate owing to infection or inflammation. It was expected that elevated VCO 2 would be accompanied by elevated heart rate in children with CF. However, in this study, children with CF had elevated VCO 2 only when lying, not when sitting or standing (Slater, 2004) . The most variable component of total CO 2 production in children is owing to physical activity.
Use of a resting value of VCO 2 will lead to an underestimation of the true amount of tracer recovered in breath, even in compliant adults. Use of non-resting VCO 2 to calculate PDR improved the specificity of the 13 C[MTG] breath test. The heart rate monitors and calibration procedure were well tolerated by all subjects including children with CF, who were free from pulmonary infection at the time of the test. Children with CF preferred the breath test to alternative non-invasive tests of exocrine pancreatic function such as 3-day faecal fat estimations (personal communication). There was no problem in sampling breath by blowing through a straw in children with CF.
Most of the control children in this study performed the breath test in their own homes, where there was a greater choice of activity than at the hospital. This was performed to demonstrate the problem of physical activity during 13 C-breath tests, that is, apparently low recovery of 13 C in breath CO 2 in some healthy subjects, and that use of nonresting VCO 2 could resolve the problem. There was a wider range of physical activity in children (1.0-2.2) than in adults (1.0-1.6), as expected. This leads to bigger errors in PDR calculation when a resting value of VCO 2 is assumed in children, than in adults. Children undertaking the test in their own home had a more variable PAL than those coming to the hospital ( Table 2 ). The median PAL in tests that were performed under more clinical conditions at the hospital, with fewer choices of activity, was 1.3, the same as that in compliant adults who remained seated during the test. This PAL is consistent with the observed behaviour and the energy cost of the activities undertaken in terms of metabolic intensity (MET) quoted by Ainsworth et al. (2000) , although a detailed activity diary was not recorded. One MET is the ratio of the metabolic rate associated with a particular activity to resting metabolic rate in adults (Ainsworth et al., 1993) . MET tables were not available for children's activities.
The problem of physical activity during 13 C-breath tests is more obvious in children, than in adults, and in pancreaticsufficient subjects than pancreatic-insufficient subjects. A 50-100% error in VCO 2 (PAL 1.5-2.0) will result in a greater absolute error in healthy subjects than in subjects with poor fat digestion, who have low 13 C excretion in breath owing to pancreatic insufficiency. If the mean cPDR in the MTG breath test in healthy subjects were approximately 30% (assuming PAL ¼ 1.0), a PAL of 2 would result in a calculated cPDR of 15% in a non-compliant subject, resulting in a falsepositive result. In the MTG test, a positive result is low recovery of 13 C in breath. A PAL of 2 in a child with CF and pancreatic insufficiency would result in a calculated cPDR of 5% instead of 10%, which would not make a difference to the clinical diagnosis. assess lipase activity in healthy children and found significantly lower recovery (after 6 h) of 13 C in the breath of teenagers aged 11-17 (range 15-35%), than of children aged 3-10 (range 25-44%). Full-term infants aged 33-121 days had similar recovery (26-44%) as to the adults in this study, when PDR was calculated using a predicted value of resting VCO 2 (29-43%), except for one infant with a low recovery of 14%. This could have been owing to poor lipase activity in this child, but it could equally be owing to increased VCO 2 , owing to physical activity during the test. The study of van Dijk-van Aalst et al. (2001) used different test meals for the infants and older children, and yet another test meal was used in this study. Different test meals may affect the rate of gastric emptying of the meal, but if breath is sampled for sufficient time, it should not affect the area under the curve (cPDR) in healthy subjects, as long as all the meals are composed of ingredients with low 13 C natural abundance (Morrison et al., 2000) . Kalivianakis et al. (1997) found that the nature of the test meal did not affect recovery of 13 C in the breath of adults. We can think of no physiological reason why teenagers would have poorer lipase activity than infants, children and adults, but have shown that increased physical activity can lead to low recovery of 13 C in the breath of healthy individuals at any age (Slater, 2004) . The recovery of 13 C, when PDR was calculated using resting VCO 2 , was in the same range as has been reported previously (Amarri et al., 1997; Swart et al., 1997; Wutzke et al., 1999; van Dijk-van Aalst et al., 2001) . There was overlap between pancreatic-sufficient and pancreatic-insufficient subjects in the cumulative amount of 13 C excreted in breath CO 2 , no matter whether the resting VCO 2 was measured or predicted. However, use of calibrated heart rate monitors to estimate non-resting VCO 2 eliminated falsenegative results in healthy children. When a variable nonresting value of VCO 2 was used, the populations of pancreatic-sufficient and pancreatic-insufficient subjects were completely separated (Figure 1 ). (1998) . In this study, the control group had lower cumulative 13 C excretion than the group with gastrointestinal diseases of nonpancreatic origin, although the upper limit was similar in both groups. One explanation for this is that patients are more compliant subjects than control subjects, especially students. If some members of the control group failed to remain seated during the test and therefore their energy expenditure and CO 2 production rate were not at resting levels throughout, the higher CO 2 production rate would result in lower breath 13 CO 2 enrichment, and therefore the PDR calculated using resting VCO 2 would be lower than the actual excretion, resulting in false-positive results and a poor PPV. Because of the small number of pancreatic-insufficient subjects in this study, data were obtained from a previous study (Amarri et al., 1997) performed under similar conditions to this study. A factor for physical activity (1.3) was applied to the 6 h cPDR, which had been calculated using measured resting VCO 2 in children with CF (n ¼ 45). The results were compared with the reference range established in this study with no loss of specificity (Figure 1 ). The cutoff, determined by TG-ROC, was 25.9% compared to the cutoff of 25.4% previously determined. Calibrated heart rate monitors can be used to establish VCO 2 and PAL under the conditions that usually occur at each centre and to establish the reference range of cPDR in healthy individuals under these conditions. The PAL measured under the conditions of the test can then be used to correct PDR for non-resting VCO 2 . This is a more practical approach for routine use of [ 13 C]MTG breath tests to assess the adequacy of PERT, and conversion to pancreatic insufficiency in children with CF, as it is not possible to routinely perform a heart rate calibration during the test.
Use of non-resting VCO 2 could lead to improvements in other 13 C-breath tests that report results in terms of PDR, especially in children. These include tests of starch digestion and fermentation (Dewit et al., 1992; Weaver et al., 1995; Christian et al., 2003) and liver function tests (Parker et al., 1994 (Parker et al., , 1997 (Parker et al., , 1998 ).
In conclusion, use of non-resting VCO 2 improved the specificity and therefore the PPV of the [ 13 C]MTG breath test, confirming our hypothesis that the poor specificity of the breath test is due, in part, to inappropriate use of resting VCO 2 to calculate PDR in breath. Calibrated heart rate monitors can be used to determine the reference range for cPDR during 13 C-breath tests in healthy children, and the PAL during the [ 
